The vision: to provide fast, affordable point-of-care sequencing that empowers clinicians to make timely therapeutic decisions for patients everywhere.
The aim: to solve the significant drawbacks of today's centralised lab model, which often involves long turnaround times, high costs, limited access, high throughput challenges, human error, and concerns over national security and privacy.
The solution: SiGenex has developed an automated, integrated benchtop NGS platform that directly brings the power of genomic sequencing to the point of care. With this technology, clinicians can obtain crucial genomic data within 24 hours, enabling faster, more informed therapy decisions that lead to better patient outcomes.
SiGenex currently operates in Kuala Lumpur, Malaysia, where it’s building an R&D centre. The company is now expanding its R&D operations to the UK under the leadership of Dr Bohao Yao, who will be based at the BioEscalator. Dr Yao is the Director of Data Science for SiGenex and brings a wealth of expertise as a deep tech data scientist and mathematician. He holds a PhD in Statistics from the University of Oxford and an MA from the University of Cambridge. Additionally, he lectures in Mathematics at Hertford College, University of Oxford.
We are very excited to be part of the BioEscalator; we look forward to collaborating with start-ups at the BioEscalator and researchers at the university to make an impact on healthcare globally.
Bohao Yao, Director of Science, SiGenex